The FTO gene, associated with various genetic conditions, plays a significant role in growth and development. When mutations occur within this gene, individuals may experience growth retardation, developmental delays, and distinct facial dysmorphisms. These manifestations highlight the importance of early detection and intervention to manage and mitigate potential complications.
DNA Labs UAE offers a specialized genetic test aimed at identifying mutations in the FTO gene. This test is crucial for individuals exhibiting symptoms related to growth retardation and developmental delays, as it can provide a definitive diagnosis, guiding further management and treatment strategies. Additionally, recognizing facial dysmorphisms linked to FTO gene mutations can aid in the early identification of affected individuals.
The cost of the FTO gene genetic test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect any mutations within the FTO gene, providing families and healthcare professionals with essential information for managing the condition. Early testing and diagnosis are key to optimizing outcomes for individuals with mutations in the FTO gene, making this test an invaluable tool in the field of genetic medicine.
The HOXA13 gene Guttmacher Syndrome genetic test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the HOXA13 gene, which are associated with Guttmacher Syndrome. This rare genetic disorder is characterized by limb and genitourinary abnormalities, impacting the development of the hands, feet, and urinary tract. The test plays a crucial role in the early diagnosis and management of the syndrome, enabling healthcare providers to offer targeted interventions and support to affected individuals and their families.
Performed using a sample of the patient's blood or saliva, the test examines the specific segments of the HOXA13 gene for any abnormalities that might indicate the presence of Guttmacher Syndrome. The accuracy and reliability of the test make it a valuable resource for genetic counseling and for making informed decisions about the management of the condition.
The cost of the HOXA13 gene Guttmacher Syndrome genetic test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the HOXA13 gene and provide individuals with critical information about their genetic health. Patients considering this test are encouraged to consult with their healthcare provider to understand its benefits and implications fully.
The "WNT7A Gene Fibular Aplasia or Hypoplasia, Femoral Bowing and Poly-, Syn-, and Oligodactyly Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the WNT7A gene. These mutations are associated with a rare congenital condition characterized by a spectrum of limb abnormalities including the absence or underdevelopment of the fibula (fibular aplasia or hypoplasia), curvature of the femur (femoral bowing), and various abnormalities of the fingers and toes such as having too many (polydactyly), fused (syndactyly), or too few (oligodactyly). This comprehensive genetic test, costing 4400 AED, is crucial for accurate diagnosis, allowing for tailored treatment and management plans for affected individuals. DNA Labs UAE employs advanced genetic testing technologies to ensure precise and reliable results, aiding in the understanding and intervention of this complex condition.
The "POLE Gene FILS Syndrome Genetic Test" is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the POLE gene that are associated with FILS syndrome. FILS syndrome is a rare genetic disorder characterized by facial dysmorphism, immunodeficiency, livedo, and short stature. The test aims to provide crucial genetic information that can help in the accurate diagnosis and management of the condition.
At DNA Labs UAE, the test is conducted with precision and care, ensuring reliable results. The cost of the test is set at 4400 AED, making it accessible to those who need it. This test is vital for families seeking answers about FILS syndrome, offering them a clear path towards understanding their genetic health and planning for any necessary treatments or interventions.
The FRAS1 Gene Fraser Syndrome Genetic Test is a specialized diagnostic assessment designed to identify mutations in the FRAS1 gene, which are associated with Fraser syndrome. Fraser syndrome is a rare autosomal recessive disorder characterized by cryptophthalmos, syndactyly, and abnormalities in other parts of the body, including the kidneys and ears. Early and accurate diagnosis through genetic testing can be crucial for management and treatment planning for affected individuals.
The test involves collecting a DNA sample, typically through a blood draw or cheek swab, and analyzing it for specific mutations in the FRAS1 gene. This gene plays a significant role in the development of the skin, eyes, and other organs, with mutations leading to the various clinical manifestations of Fraser syndrome.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the FRAS1 Gene Fraser Syndrome Genetic Test is priced at 4400 AED. The test cost reflects the comprehensive analysis and the technical expertise required to interpret the results accurately. DNA Labs UAE ensures confidentiality and provides counseling services to help patients and families understand the implications of the test results, guiding them towards appropriate medical and support services as needed.
The FREM2 Gene Fraser Syndrome Genetic Test is a specialized diagnostic procedure designed to detect mutations in the FREM2 gene, which are associated with Fraser syndrome. Fraser syndrome is a rare autosomal recessive congenital disorder characterized by cryptophthalmos, syndactyly, and abnormalities affecting the urinary system and other organs. The test is crucial for early diagnosis, enabling timely intervention and management of the condition.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test employs advanced genetic sequencing technologies to analyze the FREM2 gene for any alterations that might indicate the presence of Fraser syndrome. Understanding the genetic makeup of the syndrome not only aids in confirming the diagnosis but also helps in assessing the risk of passing the condition to future generations, making it an invaluable tool for affected families.
The cost of the FREM2 Gene Fraser Syndrome Genetic Test is set at 4400 AED. While the price may seem significant, the comprehensive insights provided by the test into one’s genetic health, potential risks, and the guidance it offers for clinical decisions, make it a worthwhile investment for individuals at risk or those seeking to understand their genetic health better in relation to Fraser syndrome.
The "GRIP1 Gene Fraser Syndrome Genetic Test" is a specialized diagnostic tool offered at DNA Labs UAE, designed to identify mutations in the GRIP1 gene, which are associated with Fraser Syndrome. Fraser Syndrome is a rare genetic disorder characterized by malformations affecting the eyes, ears, and other parts of the body. This comprehensive test aims to provide crucial genetic information for the early detection and management of the syndrome, facilitating personalized treatment plans and genetic counseling for affected individuals and their families. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately analyze the genetic variations linked to this complex condition. By opting for this test at DNA Labs UAE, patients and healthcare providers can access critical insights into the genetic underpinnings of Fraser Syndrome, paving the way for improved outcomes through targeted interventions.
The ALX3 Gene Frontonasal Dysplasia Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at detecting mutations in the ALX3 gene, which are known to cause Frontonasal Dysplasia Type 1. This condition is a rare genetic disorder characterized by a spectrum of abnormalities affecting the development of the head and face, often leading to distinct facial features, including a widened nasal bridge, a broad nose tip, and, in some cases, cleft lip and palate. The test is crucial for early diagnosis, allowing for appropriate management and counseling of affected individuals and their families. With a cost of 4400 AED, the test represents a significant step forward in the field of genetic diagnostics, providing insights into a complex condition and offering hope for affected families seeking understanding and support.
The ALX4 Gene Frontonasal Dysplasia Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the ALX4 gene, which are linked to Frontonasal Dysplasia Type 2. This condition is a rare genetic disorder characterized by a range of features including abnormalities of the head, face, and limbs. The ALX4 gene plays a crucial role in the development of these structures during embryonic growth, and mutations can lead to the distinct phenotypes associated with the syndrome.
The test is performed through a detailed analysis of the patient's DNA, looking specifically for the genetic variations within the ALX4 gene that are known to cause Frontonasal Dysplasia Type 2. This is crucial for confirming a diagnosis, understanding the risk of passing the condition to future generations, and guiding treatment and management decisions.
Priced at 4400 AED, the test is conducted at DNA Labs UAE, which is equipped with state-of-the-art technology and staffed by professionals with expertise in genetic diagnostics. The facility ensures accurate and reliable results, providing essential information for affected individuals and their families.
The FH Gene Fumarase Deficiency Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the FH gene, which can lead to Fumarase Deficiency. This rare genetic disorder interferes with the cell's ability to generate energy, leading to a spectrum of physical and developmental challenges. The test, priced at 4400 AED, involves analyzing the patient's DNA to pinpoint any genetic alterations in the FH gene, enabling early diagnosis and management of the condition. Through this test, families can gain valuable insights into the genetic makeup and potential health risks, allowing for informed decisions regarding healthcare and family planning.
